Cellectis (ADR)
Develops gene-edited allogeneic CAR-T candidates and manufacturing capabilities.
$3.41
After-hours close−0.02 (−0.58%)
At close$3.43(−2.28%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.20 | — | — |
| Aug 2026 | −$0.26 | −$0.22 | +16.3% |
| May 2026 | −$0.26 | −$0.18 | +30.3% |
| Mar 2026 | −$0.20 | −$0.26 | −27.9% |
| Nov 2025 | −$0.10 | $0.01 | +110.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.20 | — | — | $15.2M | — | — |
| Aug 6, 2026 | −$0.26 | −$0.22 | +16.3% | $11.0M | $6.9M | −37.5% |
| May 11, 2026 | −$0.26 | −$0.18 | +30.3% | $11.0M | $7.5M | −31.6% |
| Mar 19, 2026 | −$0.20 | −$0.26 | −27.9% | $13.4M | $12.2M | −8.9% |
| Nov 7, 2025 | −$0.10 | $0.01 | +110.0% | $10.3M | $35.2M | +242.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 4, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 13, 2025 | ||||||
| Nov 4, 2024 | ||||||
| Aug 6, 2024 | ||||||
| Apr 29, 2024 | ||||||
| Mar 13, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 8, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 3, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 4, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 6, 2020 | ||||||
| Mar 4, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 6, 2019 | ||||||
| May 7, 2019 | ||||||
| Mar 11, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Aug 1, 2018 | ||||||
| May 7, 2018 | ||||||
| Mar 12, 2018 | ||||||
| Nov 13, 2017 | ||||||
| Aug 2, 2017 | ||||||
| May 9, 2017 | ||||||
| Mar 6, 2017 | ||||||
| Nov 22, 2016 | ||||||
| Sep 8, 2016 | ||||||
| May 11, 2016 | ||||||
| Mar 16, 2016 | ||||||
| Nov 19, 2015 | ||||||
| Sep 9, 2015 | ||||||